Long term biweekly 1 mg oral vitamin B12 ensures normal hematological parameters, but does not correct all other markers of vitamin B12 deficiency. A study in patients with inherited vitamin B 12 deficiency

Haematologica

Volumn 93, Issue 11, 2008, Pages 1755-1758

  Bor, Mustafa Vakur ^a   Çetin, Mualla ^b   Aytaç, Selin ^b   Altay, Çigdem ^b   Ueland, Per Magne ^c   Nexo, Ebba ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HACETTEPE UNIVERSITY   (Turkey)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Cobalamin; Holo TC; Inherited vitamin B12 deficiency; Oral vitamin B12 treatment

Indexed keywords

COBALAMIN; CYANOCOBALAMIN; DEVA; HOMOCYSTEINE; METHYLMALONIC ACID; TRANSCOBALAMIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; BLOOD SAMPLING; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DRUG EFFICACY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; LETTER; MALE; SCHOOL CHILD; VITAMIN SUPPLEMENTATION;

ADMINISTRATION, ORAL; HUMANS; INTESTINAL ABSORPTION; REFERENCE VALUES; TREATMENT FAILURE; TREATMENT OUTCOME; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 55549099888     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13122     Document Type: Letter

References (12)

1. Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998;92:1191-8.
2. 12 without intrinsic factor. Acta Med Scand 1968;184:247-58.
3. Altay C, Cetin M. Vitamin B12 absorption test and oral treatment in 14 children with selective vitamin B12 malabsorption. Pediatr Hematol Oncol 1999;16:159-63.
4. Bolaman Z, Kadikoylu G, Yukselen V, Yavasoglu I, Barutca S, Senturk T. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther 2003;25:3124-34.
5. Tanner SM, Li Z, Bisson R, Acar C, Oner C, Oner R, et al. Genetically heterogeneous selective intestinal malabsorption of vitamin B12: founder effects, consanguinity, and high clinical awareness explain aggregations in Scandinavia and the Middle East. Hum Mutat 2004;23:327-33.
6. Tanner SM, Li Z, Perko JD, Öner C, Çetin M, Altay Ç, et al. Hereditary juvenile cobalamin deficiency caused by mutations in the intrinsic factor gene. Proc Natl Acad Sci USA 2005;102:4130-3.
7. Bor MV, Cetin M, Aytaç S, Altay C, Nexo E. Nonradioactive vitamin B12 absorption test evaluated in controls and in patients with inherited malabsorption of vitamin B12. Clin Chem 2005;51:2151-5.
8. Nexo E, Christensen AL, Hvas AM, Petersen TE, Fedosov SN. Quantification of holotranscobalamin, a marker of vitamin B12 deficiency. Clin Chem 2002;48:561-2.
9. Windelberg A, Arseth O, Kvalheim G, Ueland PM. Automated assay for the determination of methylmalonic acid, total homocysteine, and related amino acids in human serum or plasma by means of methylchloroformate derivatization and gas chromatography-mass spectrometry. Clin Chem 2005;51:2103-9.
10. Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720-8.
11. Gangarossa S, Romano V, Schilirò G. Efficacy of oral administration of high-dose cobamamide in a patient with Imerslund-Gräsbeck syndrome. Pediatr Hematol Oncol 1996;13:387-9.
12. Bor MV, Nexø E, Hvas AM. Holo-transcobalamin concentration and transcobalamin saturation reflect recent vitamin B12 absorption better than does serum vitamin B12. Clin Chem 2004;50:1043-9.